RE: No RNS at Market Close.2 Jul 2022 12:41
I was thinking about the fact that no RNS appeared may actually be a very good thing.
CINE already told us their projections/predictions for what they will be able to do with the RCF. They told us that they estimated BO to return to 85% and that they will be able to reduce the RCF to below 35% to avoid the test from memory. If this was any different, then CINE would have to update us. The fact that they didn’t release anything perhaps suggests that CINE has actually been able to reduce the RCF as projected, and CINE already told us that was their expectation, so perhaps they don’t need to release an RNS for it.
With the dissenting payment, if you look at the language of that RNS it talks about maximising liquidity. Not once amongst all the RNS’s for the dissenting payments does it mention them seeking the waiver so they will actually be able to pay it, it just talks about maximising liquidity. Therefore, it may be the case that CINE was able to pay these dissenting shareholders right from the very start of when they got the waiver, and there was never any concern about whether they’d be able to pay or not. Remember that CINE paid $170m on the spot already, and all they had to pay at this time was $96m, that really isn’t too much at all.
All in my opinion.